Institutional shares held 1.62 Billion
17.5M calls
15M puts
Total value of holdings $240B
$2.59B calls
$2.22B puts
Market Cap $387B
2,614,479,872 Shares Out.
Institutional ownership 62.04%
# of Institutions 4,106

Latest Institutional Activity in JNJ

Top Purchases

Q1 2024
Global Assets Advisory, LLC Shares Held: 1.08M ($159M)
Q1 2024
Norden Group LLC Shares Held: 308K ($45.5M)
Q1 2024
Artemis Investment Management LLP Shares Held: 54.3K ($8.03M)
Q1 2024
Hennessy Advisors Inc Shares Held: 53.6K ($7.92M)
Q1 2024
Quattro Financial Advisors LLC Shares Held: 43.5K ($6.43M)

Top Sells

Q1 2024
Stone Pine Asset Management Inc. Shares Held: 1.18M ($174M)
Q1 2024
Vaughan Nelson Investment Management, L.P. Shares Held: 19.7K ($2.91M)
Q1 2024
Tru Wealth Advisors, LLC Shares Held: 6K ($888K)
Q1 2024
Gateway Investment Advisers LLC Shares Held: 533K ($78.9M)
Q1 2024
Congress Asset Management CO Shares Held: 18.5K ($2.74M)

About JNJ

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Insider Transactions at JNJ

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
From 12 Insiders
Exercise of conversion of derivative security 426K shares
Grant, award, or other acquisition 790 shares
Sell / Disposition
From 22 Insiders
Payment of exercise price or tax liability 209K shares
Open market or private sale 115K shares
Sale (or disposition) back to the issuer 14.8K shares
Bona fide gift 55 shares

Track Institutional and Insider Activities on JNJ

Follow JOHNSON & JOHNSON and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if


Receive news related to JOHNSON & JOHNSON

Track Activities on JNJ